Mortality risk in COPD and Sleep Apnoea reduced by CPAP

sleepingContinuous Positive Pressure Therapy (CPAP) greatly reduces the mortality rate for people with obstructive sleep apnoea and chronic obstructive pulmonary disease (COPD) according to a new study. According to lead author, Michael L. Stanchina of the Alpert Medical School of Brown University, CPAP has time and again been shown to control risk factors in the overlap syndrome patients. 

The study identified 3,396 patients who have COPD or OSA over the period between 2007 and 2010. Among this number were 227 overlap syndrome patients who had both OSA and COPD. They were treated with CPAP therapy. From the results obtained, CPAP therapy was an independent predictor of mortality. Compliance and increased nightly hours of CPAP therapy lowered risk of death significantly.

Read the full story here

Image courtesy of yingyo /

Somnowell Inventor - Visiting Professor Simon Ash FDS MSc MOrth BDS

Prof. Ash is the inventor of the highly successful SOMNOWELL Chrome device for snoring and sleep apnoea.

The Somnowell Chrome is made to exacting standards in the Somnowell laboratory under the supervision of Visiting Professor Simon Ash. Prof. Ash and his master technicians create each Somnowell Chrome device using their wealth of experience and expertise.

Prof. Ash works at the forefront of his profession. He is a Consultant and Specialist Orthodontist with over 30 years clinical experience, with a special interest in sleep related breathing disorders, TMJD, and bruxism. He currently works in Harley Street London and two private hospitals in London as part of a multi-disciplinary team managing snoring and sleep apnoea, and is Visiting Professor of Orthodontics at the BPP University.